Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin

Journal of Experimental Medicine

Volumn 205, Issue 1, 2008, Pages 25-33

  Kon, Shigeyuki ^a   Ikesue, Masahiro ^a   Kimura, Chiemi ^a   Aoki, Momoe ^a   Nakayama, Yosuke ^a   Saito, Yoshinari ^a   Kurotaki, Daisuke ^a   Diao, Hongyan ^a   Matsui, Yutaka ^a   Segawa, Tatsuya ^b   Maeda, Masahiro ^b   Kojima, Tetsuhito ^c   Uede, Toshimitsu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Immuno Biological Laboratories Co Ltd   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; OSTEOPONTIN; SYNDECAN 4; THROMBIN; CONCANAVALIN A; PROTEOHEPARAN SULFATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; IN VIVO STUDY; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; LIVER; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CONCANAVALIN A; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HUMANS; INFLAMMATION; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOPONTIN; PROTEIN STRUCTURE, TERTIARY; SYNDECAN-4;

EID: 38749144385     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20071324     Document Type: Article

References (30)

1. Taylor, K.R., and R.L. Gallo. 2006. Glycosaminoglycans and their proteo glycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 20:9-22.
2. Echtermeyer, F., M. Streit, S. Wilcox-Adelman, S. Saoncella, F. Denhez, M. Detmar, and P. Goetinck. 2001. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107:R9-R14.
3. Ishiguro, K., K. Kadomatsu, T. Kojima, H. Muramatsu, M. Iwase, Y. Yoshikai, M. Yanada, K. Yamamoto, T. Matsushita, M. Nishimura, et al. 2001. Syndecan-4 deficiency leads to high mortality of lipopolysaccharide-injected mice. J. Biol. Chem. 276:47483-47488.
4. Woods, A., J.R. Couchman, S. Johansson, and M. Hook. 1986. Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. EMBO J. 5:665-670.
5. Bloom, L., K.C. Ingham, and R.O. Hynes. 1999. Fibronectin regulates assembly of actin filaments and focal contacts in cultured cells via the heparin-binding site in repeat III13. Mol. Biol. Cell. 10:1521-1536.
6. Midwood, K.S., L.V. Valenick, H.C. Hsia, and J.E. Schwarzbauer. 2004. Coregulation of fibronectin signaling and matrix contraction by tenascin-C and syndecan-4. Mol. Biol. Cell. 15:5670-5677.
7. Ashkar, S., G.F. Weber, V. Panoutsakopoulou, M.E. Sanchirico, M. Jansson, S. Zawaideh, S.R. Rittling, D.T. Denhardt, M.J. Glimcher, and H. Cantor. 2000. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 287:860-864.
8. Chabas, D., S.E. Baranzini, D. Mitchell, C.C. Bernard, S.R. Rittling, D.T. Denhardt, R.A. Sobel, C. Lock, M. Karpuj, R. Pedotti, et al. 2001. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 294:1731-1735.
9. Jansson, M., V. Panoutsakopoulou, J. Baker, L. Klein, and H. Cantor. 2002. Cutting edge: Attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice. J. Immunol. 168:2096-2099.
10. Weiss, J.M., A.C. Renkl, C.S. Maier, M. Kimmig, L. Liaw, T. Ahrens, S. Kon, M. Maeda, H. Hotta, T. Uede, and J.C. Simon. 2001. Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J. Exp. Med. 194:1219-1229.
11. Yumoto, K., M. Ishijima, S.R. Rittling, K. Tsuji, Y. Tsuchiya, S. Kon, A. Nifuji, T. Uede, D.T. Denhardt, and M. Noda. 2002. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc. Natl. Acad. Sci. USA. 99:4556-4561.
12. Yamamoto, N., F. Sakai, S. Kon, J. Morimoto, C. Kimura, H. Yamazaki, I. Okazaki, N. Seki, T. Fujii, and T. Uede. 2003. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J. Clin. Invest. 112:181-188.
13. Bruemmer, D., A.R. Collins, G. Noh, W. Wang, M. Territo, S. Arias-Magallona, M.C. Fishbein, F. Blaschke, U. Kintscher, K. Graf, et al. 2003. Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J. Clin. Invest. 112:1318-1331.
14. Diao, H., S. Kon, K. Iwabuchi, C. Kimura, J. Morimoto, D. Ito, T. Segawa, M. Maeda, J. Hamuro, T. Nakayama, et al. 2004. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity. 21:539-550.
15. Hur, E.M., S. Youssef, M.E. Haws, S.Y. Zhang, R.A. Sobel, and L. Steinman. 2007. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8:74-83.
16. Xanthou, G., T. Alissafi, M. Semitekolou, D.C. Simoes, E. Economidou, M. Gaga, B.N. Lambrecht, C.M. Lloyd, and V. Panoutsakopoulou. 2007. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat. Med. 13:570-578.
17. Denhardt, D.T., and X. Guo. 1993. Osteopontin: a protein with diverse functions. FASEB J. 7:1475-1482.
18. Kojima, T., C.W. Leone, G.A. Marchildon, J.A. Marcum, and R.D. Rosenberg. 1992. Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells. J. Biol. Chem. 267:4859-4869.
19. Rauch, B.H., E. Millette, R.D. Kenagy, G. Daum, J.W. Fischer, and A.W. Clowes. 2005. Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells. J. Biol. Chem. 280:17507-17511.
20. Yokosaki, Y., N. Matsuura, T. Sasaki, I. Murakami, H. Schneider, S. Higashiyama, Y. Saitoh, M. Yamakido, Y. Taooka, and D. Sheppard. 1999. The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J. Biol. Chem. 274:36328-36334.
21. Fears, C.Y., and A. Woods. 2006. The role of syndecans in disease and wound healing. Matrix Biol. 25:443-456.
22. Shworak, N.W., M. Shirakawa, R.C. Mulligan, and R.D. Rosenberg. 1994. Characterization of ryudocan glycosaminoglycan acceptor sites. J. Biol. Chem. 269:21204-21214.
23. Deepa, S.S., S. Yamada, M. Zako, O. Goldberger, and K. Sugahara. 2004. Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. J. Biol. Chem. 279:37368-37376.
24. Bao, X., T. Mikami, S. Yamada, A. Faissner, T. Muramatsu, and K. Sugahara. 2005. Heparin-binding growth factor, pleiotrophin, mediates neuritogenic activity of embryonic pig brain-derived chondroitin sulfate/dermatan sulfate hybrid chains. J. Biol. Chem. 280:9180-9191.
25. Carulli, D., T. Laabs, H.M. Geller, and J.W. Fawcett. 2005. Chondroitin sulfate proteoglycans in neural development and regeneration. Curr. Opin. Neurobiol. 15:116-120.
26. Kojima, T., N.W. Shworak, and R.D. Rosenberg. 1992. Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line. J. Biol. Chem. 267:4870-4877.
27. Rosenberg, R.D. 1989. Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. Am. J. Med. 87:2S-9S.
28. Ohshima, S., N. Yamaguchi, K. Nishioka, T. Mima, T. Ishii, M. Umeshita-Sasai, H. Kobayashi, M. Shimizu, Y. Katada, S. Wakitani, et al. 2002. Enhanced local production of osteopontin in rheumatoid joints. J. Rheumatol. 29:2061-2067.
29. Kon, S., M. Maeda, T. Segawa, Y. Hagiwara, Y. Horikoshi, S. Chikuma, K. Tanaka, M.M. Rashid, M. Inobe, A.F. Chambers, and T. Uede. 2000. Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms. J. Cell. Biochem. 77:487-498.
30. Mori, N., T. Majima, N. Iwasaki, S. Kon, K. Miyakawa, C. Kimura, K. Tanaka, D.T. Denhardt, S. Rittling, A. Minami, and T. Uede. 2007. The role of osteopontin in tendon tissue remodeling after denervation-induced mechanical stress deprivation. Matrix Biol. 26:42-53.